Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine adjunct therapy in systolic heart failure
IRCT20120215009014N333Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing N-acetylcysteine adjunct arm with Placebo adjunct arm (2 arms). Primary endpoints: Left ventricular ejection fraction, Right ventricular ejection fraction and 9 more. Started Jan 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20120215009014N333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N333.